Global Disease Detection: Accomplishments
GDD monitors and evaluates the program’s capabilities and progress on a quarterly basis. Five key activities are evaluated using a framework that includes quantitative and qualitative information.
- Provided rapid response to more than 535 disease outbreaks and other public health emergencies, including H1N1 (all GDD Centers); Hand, Foot, & Mouth Disease and Salmonella enteritidis (China); human H5N1 influenza and Q Fever (Egypt); Dengue, respiratory syncytial virus, and febrile encephalitis (Guatemala); anthrax, typhoid fever, and Crimean-Congo hemorrhagic fever (Kazakhstan); viral hemorrhagic fever, cholera, and polio (Kenya), and meningococcemia and tuberculosis (Thailand).
- In the first quarter of 2010, the program continued to improve its ability to build country and regional capacity. Outbreak responses are faster (82% received a response within 24 hours of the request for assistance), more comprehensive (71% of outbreaks involved laboratory support, and of those, 100% led to a confirmed cause.)
- Discovered 51 new pathogens. These new pathogens were either identified for the first time anywhere in the world, or newly discovered within the GDD Center regions.
- 160 pathogens can now be identified locally, up from 11 in 2006. Because this capacity had previously been unavailable, it enables sustainable disease detection capability and expedites appropriate response interventions.
- The number of Field Epidemiology Training Program (FETP) trained epidemiologists and laboratorians within GDD Center regions increased from 26 (in 2006) to 263.
- Provided short-term public health training for more than 39,000 participants worldwide. Training topics have included epidemiology, laboratory, all-hazards preparedness, risk communication, influenza, and others.
- More than 5.5 million persons are under population-based surveillance for pneumonia.
- More than 2.5 million persons are under population-based surveillance for other syndromes, including bacterial blood stream infections, diarrheal disease, febrile illness of unknown origins, invasive neurological disease, pneumococcal infections, respiratory syncytial virus infections, tuberculosis, and West Nile virus.
- GDD Centers are using these data to detect outbreaks, make policy recommendations, evaluate new interventions, and measure public health impact.
- GDD Regional Centers are working with WHO and local Ministries of Health to control the spread of respiratory infections in healthcare settings.
- GDD Regional Centers are collaborating with WHO and other partners to assess the ability of countries to meet the revised International Health Regulations.